Chris Boerner, Bristol Myers Squibb CEO (Jacquelyn Martin/AP Images)

Bris­tol My­er­s' tran­si­tion moves for­ward as it rais­es 2025 rev­enue fore­cast

Bris­tol My­ers Squibb’s evo­lu­tion af­ter sweep­ing cost-cut­ting mea­sures kept chug­ging along as the com­pa­ny re­port­ed first-quar­ter earn­ings Thurs­day morn­ing.

While over­all rev­enue de­clined by 6 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.